Upgrade to SI Premium - Free Trial

Bioventus (BVS)

11.48 -0.15 (1.29%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Bioventus (BVS) 14497 contracts of July 12.50 calls July 6, 2026 3:40 PM - StreetInsider Bioventus shares rise after Medicare reverses reimbursement cuts July 6, 2026 11:06 AM - StreetInsider Canaccord Reiterates Buy Rating on Bioventus Inc (BVS) June 16, 2026 6:37 AM - StreetInsider Form 4 Bioventus Inc. For: Jun 02 Filed by: Bartholdson John A. June 4, 2026 5:06 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: SUTTER MARTIN P June 4, 2026 4:48 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: STALNECKER SUSAN M June 4, 2026 4:48 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: NOHRA GUY P June 4, 2026 4:47 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: NEELS GUIDO J June 4, 2026 4:47 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: McMurry-Heath Michelle June 4, 2026 4:47 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: Ladone Mary Kay June 4, 2026 4:47 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: HAWKINS WILLIAM A June 4, 2026 4:46 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: Cowdy Philip G. June 4, 2026 4:46 PM - SEC Filing Form 4 Bioventus Inc. For: Jun 02 Filed by: Beyer Pat June 4, 2026 4:46 PM - SEC Filing Form 8-K Bioventus Inc. For: Jun 03 June 4, 2026 7:54 AM - SEC Filing Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference June 2, 2026 7:00 AM - Globe NewsWire Form SD Bioventus Inc. May 29, 2026 7:59 AM - SEC Filing Bioventus reiterates 2026 guidance after FDA device reclassification May 21, 2026 5:14 PM - StreetInsider Form 8-K Bioventus Inc. For: May 21 May 21, 2026 4:58 PM - SEC Filing Form 10-Q Bioventus Inc. For: Mar 28 May 6, 2026 7:49 AM - SEC Filing Form 8-K Bioventus Inc. For: May 06 May 6, 2026 7:46 AM - SEC Filing Bioventus Inc. (BVS) Tops Q1 EPS by 5c ; Offers Guidance May 6, 2026 7:34 AM - StreetInsider Bioventus Reports First Quarter Financial Results May 6, 2026 7:30 AM - Globe NewsWire TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter April 30, 2026 4:43 PM - Globe NewsWire Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026 April 28, 2026 4:15 PM - Globe NewsWire Full Article List